CareDx, Inc. (CDNA)

66.68 +1.98 (+3.07%) USD  |  NASDAQ  |  Oct 15, 16:00
66.76 +0.08 (+0.13%) After-Hours: 20:00
More

CareDx Cash from Operations (TTM) : 93.66M for June 30, 2026

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 93.66M
March 31, 2026 72.95M
December 31, 2025 42.03M
September 30, 2025 42.56M
June 30, 2025 17.72M
March 31, 2025 26.78M
December 31, 2024 38.05M
September 30, 2024 7.778M
June 30, 2024 -14.92M
March 31, 2024 -34.37M
December 31, 2023 -18.39M
September 30, 2023 -2.822M
June 30, 2023 0.278M
March 31, 2023 -3.10M
December 31, 2022 -25.24M
September 30, 2022 -28.26M
June 30, 2022 -20.80M
March 31, 2022 -7.132M
December 31, 2021 -19.29M
September 30, 2021 -16.28M
June 30, 2021 -11.45M
March 31, 2021 2.856M
December 31, 2020 33.43M
September 30, 2020 25.17M
Date Value
June 30, 2020 20.56M
March 31, 2020 0.043M
December 31, 2019 -2.769M
September 30, 2019 0.312M
June 30, 2019 0.106M
March 31, 2019 -5.356M
December 31, 2018 -4.007M
September 30, 2018 -8.153M
June 30, 2018 -10.77M
March 31, 2018 -12.08M
December 31, 2017 -14.31M
September 30, 2017 -15.22M
June 30, 2017 -14.20M
March 31, 2017 -17.07M
December 31, 2016 -16.52M
September 30, 2016 -17.44M
June 30, 2016 -19.26M
March 31, 2016 -14.93M
December 31, 2015 -9.752M
September 30, 2015 -6.498M
June 30, 2015 -7.13M
March 31, 2015 -4.544M
December 31, 2014 -3.35M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Natera, Inc. 228.24M
Caris Life Sciences, Inc. 160.85M
Myriad Genetics, Inc. 7.70M
BioRestorative Therapies, Inc. -11.82M
Exagen, Inc. -6.498M